About Circulomics
Circulomics is a Healthcare company based in Baltimore (United States) founded in 2009, and was acquired by PacBio in August 2021. Platforms for genome profiling and biomarker analysis are developed. Circulomics offers products and services including Revio System, Vega System, Onso System, HiFi Sequencing, and SMRT Link. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include Neogen, RareCyte and seqWell; 3 of its 3 listed competitors have raised funding.
Company details
Circulomics was founded in 2009 and is headquartered in Baltimore, United States. Operations focus on the genomics sector, where innovative platforms are developed for nucleic acid sample preparation, microRNA profiling, and single-molecule analysis. These technologies support research and clinical applications in sequencing, expression profiling, and biomarker analysis. Services are provided to advance the translation of genomics tools into practical use.
Products & Services of Circulomics
Circulomics offers a comprehensive portfolio of products and services, including Revio System, Vega System, Onso System, HiFi Sequencing, and SMRT Link.
Long-read sequencing platform for whole genome analysis.
Long-read sequencing for microbial and human genomics.
Short-read sequencing for variant detection applications.
High-accuracy sequencing method for research purposes.
Bioinformatics tool for sequencing data analysis.
Apps and channels of Circulomics
its YouTube channel PacBio has 6.11K subscribers and 30 videos.
Videos from Circulomics
The most watched videos on Circulomics's YouTube channel, PacBio (6.11K subscribers). Click a video to play it here.
More on PacBio.
Funding Insights of Circulomics
- Total Rounds 11
- Last Round Grant — $2M
- First Round $1.83M
(Sep 2012)
- Investors Count 3
Latest 10 of 11 funding rounds of Circulomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Circulomics
Circulomics has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include PacBio, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | pacb.com | Menlo Park, United States |
Investor details for Circulomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Circulomics
4 dated milestones of Circulomics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Circulomics is founded.
- Funding First funding round of $1.8M.
- Funding Latest funding round, Grant, of $2.0M.
- Exit Acquired by PacBio.
Competitors of Circulomics
Circulomics has 3 listed competitors in our database, 3 of them funded. They include Neogen, RareCyte and seqWell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| seqwell.com | 2014 | Beverly, United States | $24.51M | 30 | NGS-based reagents and kits are supplied for life sciences research. |
Detailed competitors of Circulomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Circulomics
Websites that share an audience with Circulomics (circulomics.com).
Websites whose visitors overlap most with Circulomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mdpi.com | 100% | 23.6M | #2,770 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Circulomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Circulomics
Complete news archive for Circulomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Circulomics
Circulomics was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Circulomics is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Circulomics was founded in 2009 and is headquartered in Baltimore, United States. Operations focus on the genomics sector, where innovative platforms are developed for nucleic acid sample preparation, microRNA profiling, and single-molecule analysis. These technologies support research and clinical applications in sequencing, expression profiling, and biomarker analysis. Services are provided to advance the translation of genomics tools into practical use.
Circulomics offers Revio System, Vega System, Onso System, HiFi Sequencing, and SMRT Link.
Yes. Circulomics was acquired by PacBio in August 2021.